Literature DB >> 30194527

Subclinical myocardial injury during vaso-occlusive crisis in pediatric sickle cell disease.

Reham Wagdy1,2, Howayda Suliman3,4, Bashayer Bamashmose4, Abrar Aidaroos4, Zuhour Haneef4, Arunima Samonti4, Fatima Awn4.   

Abstract

Acute painful crisis is the most frequent complication of sickle cell disease (SCD) in children. Recurrent vaso-occlusion may be associated with cardiac injury. The study aimed to assess silent myocardial injuries for sickle cell children during acute painful crisis by measuring serum level of troponin I and galectin-3. The study included 87 participates; study group (n = 44) sickle cell children presented at Jeddah hospitals in Saudi Arabia by painful crisis or acute illness as fever or cough (2017-2018). The controls were healthy children (n = 43). Demographic and history data were collected from the cases. Troponin I and galectin-3 were measured. Galectin-3 values were higher among cases with significant difference when compared to controls (7.5 ± 3.1 versus 3.2 ± 1.6, < 0.001). Galectin-3 at a cutoff > 5.1 ng/ml, the sensitivity was 88.64 and specificity was 88.37. Galectin-3 levels were higher for the pain crisis subgroup in comparison to acute illness group with significant difference (r 0.551*, p < 0.001*). Galectin-3 values were higher among troponin-positive cases with significant difference (p = 0.046) to troponin-negative cases.
Conclusion: Positive results of troponin I and high levels of galectin-3 in sickle cell children during acute painful crisis were potent indicators for subclinical myocardial injury. What is Known: • The hallmark of sickle cell disease is recurrent episodes of vaso-occlusive crisis which had deleterious effects on many organs. • Cardiac changes in pediatric sickle cell disease whether structural or functional are mainly attributed to chronic anemia and or pulmonary hypertension. What is New: • The observed positive results of cardiac troponin I and high values of galectin-3 in sickle cell children during vaso-occlusive crisis are strong indicator of myocardial ischemia and ongoing cardiac fibrosis respectively. • The observed correlation between biological markers (positive troponin and high galectin-3) could be an indication of subclinical cardiac injury.

Entities:  

Keywords:  Cardiac troponin; Galectin-3; Myocardial ischemia; Sickle cell disease; Vaso-occlusive crisis

Mesh:

Substances:

Year:  2018        PMID: 30194527     DOI: 10.1007/s00431-018-3231-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  23 in total

1.  Acute myocardial infarction in sickle cell anaemia associated with severe hypoxia.

Authors:  S T Saad; V R Arruda; O O Junqueira; F A Schelini; O B Coelho
Journal:  Postgrad Med J       Date:  1990-12       Impact factor: 2.401

2.  Cardiac troponin-I as a marker of myocardial dysfunction in children with septic shock.

Authors:  Fuat Gurkan; Asuman Alkaya; Aydin Ece; Kenan Haspolat; Mehmet Bosnak; Meki Bilici; Mehmet Kervancioglu; Zuhal Aritürk
Journal:  Swiss Med Wkly       Date:  2004-10-02       Impact factor: 2.193

3.  Troponin I sensitivity and specificity for the diagnosis of acute myocardial infarction.

Authors:  G Ross; F N Bever; Z Uddin; E M Hockman
Journal:  J Am Osteopath Assoc       Date:  2000-01

4.  [Abnormalities of myocardial perfusion in sickle cell disease in childhood: a study of myocardial scintigraphy].

Authors:  P Acar; C Maunoury; M de Montalembert; Y Dulac
Journal:  Arch Mal Coeur Vaiss       Date:  2003-05

5.  Subclinical ischaemic episodes during the steady state of sickle cell anaemia.

Authors:  N O Akinola; S M Stevens; I M Franklin; G B Nash; J Stuart
Journal:  J Clin Pathol       Date:  1992-10       Impact factor: 3.411

6.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

7.  Cardiac troponin I in sickle cell crisis.

Authors:  Ahmad K Aslam; Carlos Rodriguez; Ahmed F Aslam; Balendu C Vasavada; Ijaz A Khan
Journal:  Int J Cardiol       Date:  2008-02-21       Impact factor: 4.164

Review 8.  How to calculate sample size for different study designs in medical research?

Authors:  Jaykaran Charan; Tamoghna Biswas
Journal:  Indian J Psychol Med       Date:  2013-04

Review 9.  Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).

Authors:  Rui Dong; Min Zhang; Qunying Hu; Shan Zheng; Andrew Soh; Yijie Zheng; Hui Yuan
Journal:  Int J Mol Med       Date:  2017-12-05       Impact factor: 4.101

10.  Acute Crises and Complications of Sickle Cell Anemia Among Patients Attending a Pediatric Tertiary Unit in Kinshasa, Democratic Republic Of Congo.

Authors:  Michel Ntetani Aloni; Bertin Tshimanga Kadima; Pépé Mfutu Ekulu; Aléine Nzazi Budiongo; René Makuala Ngiyulu; Jean Lambert Gini-Ehungu
Journal:  Hematol Rep       Date:  2017-06-01
View more
  1 in total

Review 1.  A Scoping Review of Galectin-3 as a Biomarker of Cardiovascular Diseases in Pediatric Populations.

Authors:  Ewa Smereczyńska-Wierzbicka; Radosław Pietrzak; Bożena Werner
Journal:  Int J Environ Res Public Health       Date:  2022-04-05       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.